Alaunos Therapeutics, Inc. · NASDAQ:TCRT
Alaunos Therapeutics, Inc. shareholders
As of Jun 30, 2026, 27 institutions reported holding Alaunos Therapeutics, Inc., 3.6% of its shares. Largest: Vanguard, BlackRock and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Alaunos Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 30,061 | 1.2% | no change | Aug 13, 2026 |
| BlackRock | 21,353 | 0.84% | no change | Aug 7, 2026 |
| Geode Capital | 19,356 | 0.76% | −3,204 | Aug 12, 2026 |
| Citadel | 11,870 | 0.47% | +1,351 | Aug 14, 2026 |
| Osaic Holdings, Inc. | 1,731 | 0.07% | −48 | Aug 14, 2026 |
| Tower Research Capital LLC (TRC) | 1,621 | 0.06% | +38 | Aug 11, 2026 |
| Arax Advisory Partners | 1,216 | 0.05% | new | Aug 10, 2026 |
| UBS | 992 | 0.04% | −1,282 | Aug 13, 2026 |
| Morgan Stanley | 836 | 0.03% | +183 | Aug 13, 2026 |
| Wells Fargo | 388 | 0.02% | +198 | Aug 14, 2026 |